When Regulations Feel Like a Dead End, the Real Problem is Usually the Strategy

Canadian Class II Medical Device Distributor | $2M → $3.5M Revenue | 18 Months


The Situation

A Canadian distributor of a non-invasive Class II medical device had built their entire sales model around something that no longer existed: the room.

For years, the founder had driven revenue through in-person educational seminars — a format that worked because the product required education to sell, and because Health Canada regulations made traditional marketing essentially off-limits. No paid ads. No health claims. No language that implied therapeutic outcomes. The in-person seminar was the workaround that worked, until it didn't.

A manufacturing hiatus disrupted sales flow, and when it resumed, the tradeshow and seminar circuit had collapsed entirely. So had their pipeline. Sales dropped by half. And the founder, who had spent years believing that her physical presence was the only thing that could move the product, was running out of options she could see.


The Diagnosis

When I came in, the instinct was to find a way to get back into rooms. My diagnosis was different.

The real constraint wasn't regulatory — it was strategic. The business had conflated how they had always sold with how the product had to be sold. Health Canada compliance had become a source of fear rather than a framework, and that fear had kept them in a cycle of small, under-promoted events marketed to the same 1,000-person email list that hadn't grown in years.

There was no lead generation engine. There was no system. There was a founder manually carrying every sale across the finish line, and a shrinking audience watching her do it.

The compliance problem was real, but it was solvable. The growth problem was the one that needed addressing first.


The Architecture

The system I built was designed around one core insight: Health Canada restricts what you can say about a product, not what you can teach about a condition.

The entry point was a deeply researched, expertly written PDF guide on understanding and managing chronic pain — gated behind a subscribe form and promoted publicly. It was educational content in the truest sense: evidence-based, genuinely useful, and written for someone who was suffering and looking for answers. The device never appeared by name. The treatment modality offered by the client's product appeared as one evidence-supported modality among several - without naming the product. That distinction kept the content fully compliant and made it genuinely worth subscribing for.

What followed was a sequenced email education series built to mirror the guide's structure — each message going deeper on one element of chronic pain management, slowly and logically building toward the product's modality as the topic warranted it. By the time subscribers understood the mechanism, the product's relevance was self-evident.

The founder's seminar — the 90-minute room-dependent pitch she believed was irreplaceable — was dismantled and rebuilt. The education lived in the email sequence. The remaining 10%, paired with a sales presentation, became a pre-recorded automated webinar. A follow-up sequence invited webinar attendees to a one-on-one call for deeper conversation and a close.

The founder's job went from carrying every prospect through the entire journey to showing up at the end of a system that had already done most of the work.


The Outcomes

Revenue grew from $2M to $3.5M within 18 months, with sustained upward trajectory.

The email list grew from 1,000 to 5,000 subscribers — people who had opted in because the content was worth having, not because they'd been sold to. The webinar converted at 17%. The follow-up sequence closed an additional 8%.

But the outcome that mattered most hadn't been on anyone's goal list when we started.

The founder — who had genuinely believed that her presence, her voice, and her time were the only things keeping the business alive — got her life back. She had convinced herself that the work required her. The system proved otherwise. She told me later that she honestly didn't know what to do with herself. She started spending more time with her family and grandchildren. That hadn't felt possible before.

The business didn't just grow. It became something she could own instead of something that owned her.


The Takeaway

Regulated industries don't need less marketing. They need smarter architecture — systems built with compliance as a design constraint, not an afterthought or an excuse.

When the rules tell you what you can't say, the question becomes: what can you teach?

That's usually where the answer lives.